Clinical Trial Update: VisR for Noninvasively Interrogating Stromal Collagen Organization as a Breast Cancer Biomarker: Evaluation of Compression in Control Subjects

View source ↗

Summary

This clinical trial update reports findings from evaluating VisR, a noninvasive method to interrogate stromal collagen organization as a breast cancer biomarker…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Breast Cancer | Status: COMPLETED